ACEP 2019, October 26, 2019
LIFE-THREATENING BLEEDING IN THE ANTICOAGULATED PATIENT MULTIDISCIPLINARY CASE-BASED MANAGEMENT
Featured
Use of Oral Anticoagulants: Coumadin, Factor IIa, and Factor Xa
Treatment of Severe Bleeding in the ED: 4 Factor PCCs, Idarucizumab, and Andexanet Alfa
ANNEXA-4 Trial: Full Study Report and Considerations for Treatment of Major Hemorrhage
Development of an ED-based Severe Bleeding Treatment Algorithm for Anticoagulated Patients
Optimal Prehospital Care for the Exsanguinating Anticoagulated Patient
Role of the Hospitalist in Treating Severe Bleeding for Anticoagulated Patients
Caring for the Anticoagulated Trauma Victim and Those Requiring Emergent Surgery
Upper Gastrointestinal & Mucosal Bleeding: When Do You Use Reversal Agents?
Intracranial Bleeding Catastrophes and Safely Performing Procedures in the Anticoagulated Neurocritical Care Patient